ESC Professional Premium Access

Hydrochlorothiazide does not lead to phototoxic reactions and DNA damage in healthy volunteers the HCTox study

Congress Presentation

About the speaker

Doctor Felix Goetzinger

University hospital of Saarland (UKS), Homburg (Germany)
0 follower

7 more presentations in this session

Intensive reduction of high normal blood pressures: PRINT-TAHA9 randomized clinical trial

Speaker: Associate Professor A. Attar (Shiraz, IR)


Results from a phase 1 multiple ascending dose study demonstrating safety and selectivity of aldosterone synthase inhibitor CIN-107

Speaker: Doctor M. Freeman (Boston, US)


Differentiated approach to the treatment of uncomplicated hypertensive crisis

Speaker: Doctor M. Sadulloeva (Tashkent, UZ)


Blockade of the renin-angiotensin system as a therapeutic target of NAFLD: results of an experimental model of hypercholesterolemia

Speaker: Professor D. Bertolim Precoma (Campina Grande do Sul, BR)


Comparative effect of 3 different fix-combination antihypertensive treatments in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

Speaker: Doctor A. Liontos (Ioannina, GR)


Access the full session

Hypertension - Pharmacotherapy

Speakers: Doctor F. Goetzinger, Associate Professor A. Attar, Doctor M. Freeman, Doctor M. Sadulloeva, Professor D. Bertolim Precoma...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb